Review



rmif 300-69  (PeproTech)


Bioz Verified Symbol PeproTech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    PeproTech rmif 300-69
    MIF promoted proliferation of BPH-1 <t>and</t> <t>PWR-1E</t> cells. (A) MTT assay showed the proliferation of BPH-1 cells treated with various concentrations of <t>rMIF</t> for 3 days. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+ISO-1 (10 µM) and ISO-1 (10 µM), respectively. Data are presented as mean±s.d., n =3. (C) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (E) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. * P <0.05, * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Rmif 300 69, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rmif+300-69/rmif+300+69/pmc07673366-183-17-19
    Average 90 stars, based on 1 article reviews
    rmif 300-69 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling"

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    Journal: Biology Open

    doi: 10.1242/bio.053447

    MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) MTT assay showed the proliferation of BPH-1 cells treated with various concentrations of rMIF for 3 days. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+ISO-1 (10 µM) and ISO-1 (10 µM), respectively. Data are presented as mean±s.d., n =3. (C) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (E) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. * P <0.05, * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Figure Legend Snippet: MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) MTT assay showed the proliferation of BPH-1 cells treated with various concentrations of rMIF for 3 days. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+ISO-1 (10 µM) and ISO-1 (10 µM), respectively. Data are presented as mean±s.d., n =3. (C) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (E) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. * P <0.05, * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Techniques Used: MTT Assay, CCK-8 Assay, Control, Comparison

    Flow cytometry test that MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Figure Legend Snippet: Flow cytometry test that MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Techniques Used: Flow Cytometry, Control, Comparison

    MIF modulation COX-2 and P53 signaling pathway. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Figure Legend Snippet: MIF modulation COX-2 and P53 signaling pathway. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Techniques Used: Western Blot, Expressing, Control, Comparison

    COX-2 is a key factor of MIF promoted proliferation. (A) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+celecoxib (5 µM) and celecoxib (5 µM), respectively. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (C) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Figure Legend Snippet: COX-2 is a key factor of MIF promoted proliferation. (A) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+celecoxib (5 µM) and celecoxib (5 µM), respectively. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (C) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Techniques Used: CCK-8 Assay, Control, Comparison

    Flow cytometry test that COX-2 is a key factor of MIF promoted proliferation. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Figure Legend Snippet: Flow cytometry test that COX-2 is a key factor of MIF promoted proliferation. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Techniques Used: Flow Cytometry, Control, Comparison

    Expression of signaling molecules COX-2 and P53 involved in the inhibition of COX-2. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Figure Legend Snippet: Expression of signaling molecules COX-2 and P53 involved in the inhibition of COX-2. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Techniques Used: Expressing, Inhibition, Western Blot, Control, Comparison

    Related Articles

    MTT Assay:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    CCK-8 Assay:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Control:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Comparison:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Flow Cytometry:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Western Blot:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Expressing:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Inhibition:

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: Fifteen thousand BPH-1 and PWR-1E cells were plated in each well of 96-well plates, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
    Article Snippet: BPH-1 cells and PWR-1E cells were plated on 96-well plates (1000 cells per well) overnight and rMIF (300-69, PeproTech, USA; 100 ng/ml), MIF inhibitor ISO-1 (S7732, Selleck, USA; 10 μM), COX-2 inhibitor celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.



    Similar Products

    90
    PeproTech rmif 300-69
    MIF promoted proliferation of BPH-1 <t>and</t> <t>PWR-1E</t> cells. (A) MTT assay showed the proliferation of BPH-1 cells treated with various concentrations of <t>rMIF</t> for 3 days. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+ISO-1 (10 µM) and ISO-1 (10 µM), respectively. Data are presented as mean±s.d., n =3. (C) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (E) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. * P <0.05, * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.
    Rmif 300 69, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rmif+300-69/rmif+300+69/pmc07673366-183-17-19
    Average 90 stars, based on 1 article reviews
    rmif 300-69 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) MTT assay showed the proliferation of BPH-1 cells treated with various concentrations of rMIF for 3 days. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+ISO-1 (10 µM) and ISO-1 (10 µM), respectively. Data are presented as mean±s.d., n =3. (C) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (E) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. * P <0.05, * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Journal: Biology Open

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    doi: 10.1242/bio.053447

    Figure Lengend Snippet: MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) MTT assay showed the proliferation of BPH-1 cells treated with various concentrations of rMIF for 3 days. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+ISO-1 (10 µM) and ISO-1 (10 µM), respectively. Data are presented as mean±s.d., n =3. (C) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. (E) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. Data are presented as mean±s.d., n =3. * P <0.05, * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Techniques: MTT Assay, CCK-8 Assay, Control, Comparison

    Flow cytometry test that MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Journal: Biology Open

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    doi: 10.1242/bio.053447

    Figure Lengend Snippet: Flow cytometry test that MIF promoted proliferation of BPH-1 and PWR-1E cells. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+ISO-1 and ISO-1, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Techniques: Flow Cytometry, Control, Comparison

    MIF modulation COX-2 and P53 signaling pathway. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Journal: Biology Open

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    doi: 10.1242/bio.053447

    Figure Lengend Snippet: MIF modulation COX-2 and P53 signaling pathway. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+ISO-1. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Techniques: Western Blot, Expressing, Control, Comparison

    COX-2 is a key factor of MIF promoted proliferation. (A) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+celecoxib (5 µM) and celecoxib (5 µM), respectively. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (C) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Journal: Biology Open

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    doi: 10.1242/bio.053447

    Figure Lengend Snippet: COX-2 is a key factor of MIF promoted proliferation. (A) CCK8 assay showed the proliferation of BPH-1 cells treated with control, rMIF (100 ng/ml), rMIF (100 ng/ml)+celecoxib (5 µM) and celecoxib (5 µM), respectively. Data are presented as mean±s.d., n =3. (B) CCK8 assay showed the proliferation of PWR-1E cells treated with control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (C) JC-1 assay showed the growth rates of the BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. (D) JC-1 assay showed the growth rates of the PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Techniques: CCK-8 Assay, Control, Comparison

    Flow cytometry test that COX-2 is a key factor of MIF promoted proliferation. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Journal: Biology Open

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    doi: 10.1242/bio.053447

    Figure Lengend Snippet: Flow cytometry test that COX-2 is a key factor of MIF promoted proliferation. (A) Flow cytometry showed cell cycle in BPH-1 cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (B) Histogram for S+G2/M phase of the cell cycle results in BPH-1 cells. Data are presented as mean±s.d., n =3. (C) Flow cytometry showed cell cycle in PWR-1E cells treated by control, rMIF, rMIF+celecoxib and celecoxib, respectively. (D) Histogram for S+G2/M phase of the cell cycle results in PWR-1E cells. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Techniques: Flow Cytometry, Control, Comparison

    Expression of signaling molecules COX-2 and P53 involved in the inhibition of COX-2. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Journal: Biology Open

    Article Title: The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling

    doi: 10.1242/bio.053447

    Figure Lengend Snippet: Expression of signaling molecules COX-2 and P53 involved in the inhibition of COX-2. (A) Western blotting detected the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib, respectively. (B) Western blot analysis: the expression of COX-2 and P53 in BPH-1 cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. (C) Western blotting detected the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib, respectively. (D) Western blot analysis: the expression of COX-2 and P53 in PWR-1E cells treated by control, rMIF and rMIF+celecoxib. Data are presented as mean±s.d., n =3. * P <0.05. Statistical analyses were performed using ANOVA followed by Tukey's test for multiple comparison.

    Article Snippet: One hundred thousand BPH-1 and PWR-1E cells were seeded into each well of a six-well plate, and rMIF (300-69, PeproTech, USA; 100 ng/ml), ISO-1 (S7732, Selleck, USA; 10 μM), celecoxib (S1261, Selleck, USA; 5 μM) or nothing was added into each well.

    Techniques: Expressing, Inhibition, Western Blot, Control, Comparison